• Dr. Jay Varma, who served as former NYC Mayor Bill De Blasio’s Senior Health Advisor during the Covid outbreak, was exposed last week for engaging in sex parties and a dance party while demanding that New Yorkers socially distance, stay home, and lock down their businesses. Dr. Varma also bragged about being responsible for imposing the NYC Covid vaccine mandates. He has since been fired by his latest employer, SIGA Technologies, after these revelations came to light.
• Dr. Jay Varma, former Chief Medical Officer, SIGA Technologies: “You can spin them [Monkeypox drug TPOXX test results] so that people are – won’t like, dump the stock thinking that the company is worthless.”
• Dr. Varma: “So, I’m doing that [spinning TPOXX test results] for the reporters and other people so that they could give us – it’s very complicated -- but they [FDA] could give us something called an Emergency Authorization where they would say, ‘Okay, your data is good enough.’ For like -- this is what they [FDA] did during Covid, like the vaccines and everything. They actually had to submit the data, but they took the preliminary data. They didn’t wait until the data was followed out for three or six months because it was an emergency.”
• Dr. Varma: “We need to design more studies, but we also need to keep up the people’s belief that the [TPOXX] drug works. So, that’s why spinning it in the media is helpful, because basically what we’re trying to get the media to say is, ‘Oh, the drug didn't work because it was designed the wrong way. So, they’re going to do another study, and it’ll probably work. And in the meantime, you know, people should prescribe it for that reason as an emergency drug.’ That's what we want the story to be.”
• Dr. Varma: “Honestly, in the United States, the risk [for Monkeypox] is very low. It’s only primarily transmitted among gay men. It basically got into the sexual networks of gay men, and a lot of gay men have tons and tons of sexual partners and often don’t use condoms.”
• Dr. Varma: “…It’s not going to spread among the general population. It’s almost certainly going to stay primarily among gay men and maybe some women in certain segments.”

[NEW YORK – Sept. 25, 2024] Louder with Crowder’s MugClub Undercover unit released a second video today exposing Dr. Jay Varma, who was the Chief Medical Officer for SIGA Technologies up until Monday of this week.

He served as former NYC Mayor Bill De Blasio’s Senior Health Advisor during the Covid outbreak and was exposed last week for engaging in sex parties and a dance party while demanding that New Yorkers socially distance, stay home, and lock down their businesses.

Dr. Varma also bragged about being responsible for imposing the NYC Covid vaccine mandates. He has since been fired by SIGA Technologies after these revelations came to light.

“So, I'm right now – yeah -- I'm a Chief Medical Officer of a small pharmaceutical company. We make drugs for, like, really rare infectious diseases, and so – I spent my career -- I worked for the CDC for 20 years. So, I kind of lived all over the world doing infectious disease work. And so, this is the first time I’ve been in the private sector,” he said prior to being fired this week.

The former SIGA Chief Medical Officer talks about how he was trying to sell the company’s Monkeypox drug, TPOXX, to the public as well as SIGA investors.

After the TPOXX drug test results did not obtain its intended success, Dr. Varma told a MugClub Undercover journalist that he would “spin” the results to reporters because it would help protect SIGA’s stock value.

“You can spin them so that people are – won’t like, dump the stock thinking that the company is worthless,” he said.

Dr. Varma explained how the process of spinning results with the media was also important in order to obtain a potential FDA Emergency Authorization approval, similar to how the Covid vaccines were approved.

“So, I’m doing that [spinning TPOXX test results] for the reporters and other people so that they could give us – it’s very complicated -- but they [FDA] could give us something called an Emergency Authorization where they would say, ‘Okay, your data is good enough.’ For like -- this is what they [FDA] did during Covid, like the vaccines and everything. They actually had to submit the data, but they took the preliminary data. They didn’t wait until the data was followed out for three or six months because it was an emergency,” he said.

“We need to design more studies, but we also need to keep up the people’s belief that the [TPOXX] drug works. So, that’s why spinning it in the media is helpful, because basically what we’re trying to get the media to say is, ‘Oh, the drug didn't work because it was designed the wrong way. So, they’re going to do another study, and it’ll probably work. And in the meantime, you know, people should prescribe it for that reason as an emergency drug.’ That's what we want the story to be,” he said.

“So, we want the Food and Drug Administration, the FDA, to approve our drug specifically for Monkeypox. And right now, it's only considered experimental, and they won't approve it based on this study.”

The former SIGA Chief Medical Officer appeared to be displeased with the company’s employees once he learned that TPOXX test results were not successful.

“Why did they design it the wrong way? I wasn’t part of the company. My boss wasn’t part of the company. They weren't thinking about this [Monkeypox] disease. They were thinking about a whole other different disease called Smallpox. And this was part of my conference calls. I was like screaming, like, ‘Why the f*ck didn’t we design the study right?”

Contrary to what Dr. Varma has said publicly in the past, the former SIGA Chief Medical Officer told the MugClub Undercover journalist that Monkeypox disease does not present the level of threat to the United States that global health institutions purport it to be.

“Honestly, in the United States, the risk [for Monkeypox] is very low. It’s only primarily transmitted among gay men. It basically got into the sexual networks of gay men, and a lot of gay men have tons and tons of sexual partners and often don’t use condoms,” he said.

“…It’s not going to spread among the general population. It’s almost certainly going to stay primarily among gay men and maybe some women in certain segments.”

Because of that, Dr. Varma expressed doubt if it was financially worthwhile for SIGA to proceed with TPOXX testing, given how few people in the United States are proportionally at risk of contracting Monkeypox.

“So, my boss is trying to figure out the – she’s the money person, okay. I'm supposed to be the thinker,” he said.

“It’s not that many patients have the [Monkeypox] disease, which is why my CEO has to decide. Is it worth it? Because there’s only a few thousand cases in the United States. Does it really make sense to do another study that's going to cost $10 million, or to do – okay, if you’re not going to make that much money on the other hand?”

Dr. Varma went on to describe the relationship that SIGA Technologies has with U.S. federal agencies.

“So, the same drug that we make is also used for – there’s a disease called Smallpox, which was like eradicated from the Earth, like in the 1970s through vaccines,” he said.

“But it was like, some countries developed it as like, a biological weapon, like if you can spread it through the air to kill people. So, we sell it to the U.S. government -- sell this drug to the U.S. government and to other governments. It kind of was like an insurance. So, they have like a stockpile. And so, a lot of times we have to go and like meet and have to scare people and say, ‘Oh, you know, this is yeah -- you're going to die if you don't make sure we have enough of the drugs.’”

The former SIGA Chief Medical Officer also described how connected he is to the global scientific establishment.

“I have contacts to everybody -- kind of -- in any level in the health world and including particularly globally. Like, I have a lot of like -- I can contact all the people who are in the World Health Organization. They all know me. And yeah, I'm on a big advisory committee for the World Health Organization, [on] how to detect outbreaks around the world.”